Status:
COMPLETED
Mobile Health Technology for Personalized Tobacco Cessation Support Among Cancer Survivors in Laos
Lead Sponsor:
University of Oklahoma
Collaborating Sponsors:
Setthathirath Hospital
Lao National Cancer Center
Conditions:
Cigarette Smoking
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
The parent project (1R21CA253600-01, R21 phase: 9/1/2020-8/31/2022, R33 phase: 9/1/2022-8/31/2025) aims to adapt and evaluate the efficacy of our theoretically and empirically based mobile health (mHe...
Detailed Description
Stage 1: Further adapt the AT intervention Before conducting the RCT, the investigators will use a multi-step process to adapt our already developed AT intervention for use by the target populations (...
Eligibility Criteria
Inclusion
- Aged ≥18 years
- Self-reported current combustible cigarette smokers (smoked at least 100 cigarettes in lifetime and currently smoke ≥1 cigarette/day)
- Willing to set a quit date within 2 weeks of study enrollment
- Able to provide written informed consent to participate
- Able to read Lao (score ≥4 points on the Rapid Estimate of Adult Literacy in Medicine-Short Form).
Exclusion
- History of a medical condition that precludes use of NRT
- Ineligibility to participate based on medical or psychiatric conditions diagnosed by a physician/clinician
- Enrollment in another cessation program or current use of other cessation medications
Key Trial Info
Start Date :
April 20 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 31 2023
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT05253573
Start Date
April 20 2022
End Date
August 31 2023
Last Update
August 28 2024
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Lao National Cancer Center
Vientiane, Laos
2
Setthathirath Hospital
Vientiane, Laos